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Abstract 
 
Christopher O. Barnes: Protein In-Cell NMR in Escherichia coli 
(Under the direction of Professor Gary J. Pielak, Ph.D.) 
 
 
The inside of the cell is a crowded and complex environment that is impossible to 
duplicate by studying proteins and other molecules in dilute solution. The effects of 
macromolecular crowding are potentially important to all cellular functions, but until 
recently studies have been conducted mostly in dilute solution. In-cell Nuclear Magnetic 
Resonance (NMR) spectroscopy is becoming an important tool in studying proteins 
under physiologically relevant conditions. In some instances, however, protein signals 
from leaked protein are seen in the supernatant surrounding the in-cell slurry. I 
examined how expression levels contribute to protein leakage. I also describe a device 
and system that provides a controlled environment for NMR experiments in living cells. I 
have utilized this device to study the expression of the natively disordered protein α-
synuclein, inside Escherichia coli. In the future, we hope to make progress in using this 
device to study proteins in eukaryotic cells with NMR.  
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1 Introduction 
1.1 Implications of a crowded cellular environment 
 The inside of the cell is a complex entity whose characteristics are hard to define 
and difficult to emulate in vitro. Macromolecules comprise at least 30% of the cell’s 
volume, while water comprises the other 50-70% depending on extracellular conditions 
[1]. Macromolecular concentrations, however, can be greater than 300 g/L within the 
cell [2], and where crowding can affect many cellular functions. In comparison, 
macromolecular concentrations are <10 g/L for experiments carried out in vitro. For this 
reason, scientist have long been interested in studying proteins and polysaccharides in 
concentrated systems [3].  
 Recent studies that attempt to mimic the cellular environment have shown 
significant effects on protein stability, diffusion, structure, association, and metabolism. 
The effects of macromolecular crowding on protein association and dissociation are 
debatable. Crowding has been shown to effect in the formation of enzymatic complexes 
[4]. Other work, however, has show that the effects of crowding on the association of 
protein complexes can be equal to that found in dilute solution [5]. Regardless, the 
complex formation promotes metabolite channeling, which is considered key to cellular 
function [6].  The crowded cellular environment also hinders protein diffusion  in the 
cytoplasm of Escherichia coli compared to experiments in dilute solution [7-11].  
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Excluded volume theory helps explain the effects of macromolecular crowding. 
This theory states that two molecules cannot occupy the same space at the same time, 
thus making some volume inaccessible to the protein. The resulting steric exclusion 
causes globular proteins to favor the compact state by destabilizing the more open 
denatured state [12, 13]. Through the use of amide-proton NMR exchange experiments, 
macromolecular crowding, by synthetic polymers, has been shown to stabilize a 
globular protein [14, 15]. Conversely, other studies report minimal increases, or even a 
decrease in protein stability [16, 17]. In addition, crowding can affect other structural 
properties like aggregation, shape and folding dynamics or functional properties like 
ligand binding [16, 18].   
The works cited above are only a taste of data collected in recent years. 
Nevertheless, the conclusion is clear: the effects of macromolecular crowding should be 
an essential consideration when studying proteins and other macromolecules in vitro. 
These experiments, however, are imperfect because most crowding agents studied so 
far (i.e. synthetic polymers) are inert and homogenous, conditions unlike the inside of a 
cell. Therefore, there exists a need to observe the behavior of macromolecules within 
the cell. In-cell Nuclear Magnetic Resonance (NMR) spectroscopy may be the novel tool 
to achieve this goal.  
1.2 Protein in-cell NMR 
 In-cell NMR is a technique that can provide atomic level information about 
isotopically-enriched macromolecules inside cells. Initial in-cell NMR experiments 
quantified rotational mobility of enzymes in yeast, by incorporating 5-fluorotryptophan 
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and using 19F NMR [19]. This technique was later adapted to incorporate 15N and 
eventually 13C active nuclei into proteins and other macromolecules [20, 21].  
 The Pielak lab was the first to investigate intrinsically disordered proteins in cells. 
The protein, Flgm, showed a disappearance in crosspeaks corresponding to the C-
termini suggesting a gain in structure for this region of the protein [22]. Another protein, 
α-synuclein, was shown to be protected in the periplasm from a conformational change 
seen in dilute solution at 35 °C [23]. In brief, other studies have shown that in-cell NMR 
can be used to study structural changes in proteins, protein-ligand binding, and protein-
protein interactions in E. coli [24]. Progress has also been made in using in-cell NMR in 
eukaryotic systems [25, 26]. These results show the need to study proteins in 
physiologically relevant environments. 
Nevertheless, no tool is perfect. One disadvantage of NMR spectroscopy is its 
low sensitivity. Selective isotopic enrichment or labeling of the targeted species with an 
NMR active nucleus (e.g., 15N, 13C or 19F) is one way around this problem. Serber et al. 
suggest that the minimum concentration of the protein under study should be at least 
~150 µM for 15N enrichment, ~50 µM for 13C enrichment, or ~50-100 µM for 19F 
enrichment  [20, 27]. Therefore, the target protein must be overexpressed or high 
concentrations must be introduced into the cell by other means. Nonetheless, 15N 
enrichment and overexpression are no guarantee of the ability to collect high resolution 
NMR data for globular proteins inside E. coli [27]. In addition, certain proteins leak from 
cells resulting in invalid in-cell NMR data [27-29]. One last drawback to high-resolution 
in-cell NMR experiments is the need for highly dense cell samples to overcome the 
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inherit insensitivity of NMR. Higher cell densities, however, results in decreased cell 
viability, especially for eukaryotic systems.  
The research I present addresses these disadvantages. I attempt to answer two 
questions: does overexpression lead to protein leakage, and can a system be 
developed to maintain cell viability, while preserving sensitivity? The results of my 
research will be presented in the subsequent chapters. The last chapter summerizes my 
results and describes progress in applying our system to eukaryotic cells.  
  
 
 
2 Escherichia coli expression levels and in-cell protein NMR 
2.1 Introduction  
The cellular environment is complex, with macromolecular concentrations 
approaching 400 g/L [2]. Most proteins are studied outside cells in dilute solution with 
macromolecular concentrations of 10 g/L or less. There can be discrepancies when 
studying proteins in dilute solution compared to the crowded cellular environment [14, 
17, 18, 23, 28]. There is, therefore, a need to study proteins under physiologically 
relevant conditions.  
15N enrichment and overexpression alone are often insufficient  to obtain high 
quality in-cell NMR spectra of the protein of interest in Escherichia coli [27]. Specifically, 
the intracellular environment causes resonances to broaden beyond the detection limit 
in two-dimensional NMR spectra. This situation makes it likely that leaked proteinl will 
cause artifactual results [24, 27, 29].  
Here, we investigate the connection between overexpression and leakage. We 
studied four proteins. One protein α-synuclein, is a 14.4 kDa intrinisically disordered 
protein that has been observed in both the periplasm and cytoplasm of the cell [11, 23]. 
HdeA, a 11.8 kDa globular dimer, is exclusively found in the periplasm  [23, 30]. We 
also studied chymotrypsin inhibitor 2 (CI2), a 7.4 kDa protein, normally found in the 
cytoplasm but has also been shown to localize in the periplasmic space [27, 31], and 
ubiquitin, a 8.5 kDa well studied globular protein [31, 32].  
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2.2 Materials and Methods 
2.2.1 Cultivation of E. coli for in-cell NMR  
The pET-21 c(+) plasmid containing the HdeA gene was transformed into E. coli 
Bl-21 (DE3) Gold cells (Strategene). Plasmid containing cells were selected with 0.1 
mg/mL ampicillin. A 5 mL overnight culture was grown from a single colony. The 
overnight culture was used to inoculate a 100 mL culture of M9 minimal media [20] 
containing 1 g/L 15NH4Cl. The culture was incubated  at 37°C in a rotary shaker (225 
rpm, New Burnswick Scientific, Model I-26). After reaching an absorbance at 600 nm 
(A600) of 0.6-0.8, the culture was induced with isopropyl β-D-thiogalactopyranoside 
(IPTG) to a final concentration of 1 mM. The culture was placed in the rotary shaker 
(225 rpm) at 37°C. After 1.5 h, a 50 mL aliquot was pelleted using a swinging bucket 
centrifuge (Sorvall RC-3B, H6000A rotor) at 1600g for 20 min at 4°C. The pellet was 
resuspended in 1 mL of Phosphate Buffered Saline (PBS, 3.2 mM Na2HPO4, 0.5 mM 
KH2PO4, 1.3 mM KCl, 135 mM NaCl, pH 7.4). The other 50 mL was allowed to express 
protein for 3 h before processing as described above. 
Immediately after obtaining in-cell NMR spectra, cells were pelleted by 
centrifugation (Eppendorf model 5418) at 2000g for 10 min at room temperature. The 
supernatant was removed for NMR experiments. The resulting cell pellet was 
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resuspended in 1 mL lysis buffer (50 mM Tris, 150 mM NaCl, pH 8.0) and sonicated 
(Branson Ultrasonics, Fischer Scientific) for 1 min with a duty cycle of 4 s on 2 s off. The 
lysate was harvested by centrifugation (Eppendorf model 5418) at 14,000g for 5 min at 
room temperature.  
 
2.2.2  Intracellular Protein Concentrations 
The pET-21c (+), pT7-7, pET-21 and pET-46 plasmids containing the genes for 
HdeA, α-synucelin, chymotrypsin inhibitor 2 (CI2), and ubiquitin respectively, were 
transformed into E. coli Bl-21 (DE3) Gold cells (Strategene). Plasmid containing cells for 
HdeA, α-synucelin and ubiquitin were selected with 0.1 mg/mL ampicillin. Plasmid 
containing cells for CI2 were selected with 0.06 mg/mL kanamycin. Cells were grown 
and proteins expressed as described above. After 1.5, 2 and 3 h of expression an 
aliquot was diluted with PBS so that the A600 was 1.0, which equals 6.0 x 10
8 cells [33]. 
A 1 mL aliquot was removed from the diluted samples and centrifuged (Eppendorf 
model 5418) at 14,000g for 2 min at room temperature. The concentrations were 
calculated as described by a previous study [11]. 
 
2.2.3 NMR  
Data were acquired at the UNC Biomeolcular NMR facility on a Varian Inova 600 
MHz NMR spectrometer. Data were processed and visualized with NMRpipe and 
NMRviewJ, respectively [34, 35].  
8 
 
Samples for simple in-cell NMR experiments comprised 90:10 (v:v) mixture of 
resuspended cells: D2O in a standard 5 mm NMR tube. 
1H-15N HMQC (ref) spectra were 
acquired at 37oC with a 5 mm Varian Triax triple resonance probe (1H sweep width: 
11990.40 Hz; 15N sweep width: 2100 Hz, 32 transients, 128 increments).  Each 
spectrum required 35 min.  
Supernatant samples for NMR experiments comprised 90:10 (v:v) mixture of 
supernatant: D2O in a standard 5 mm NMR tube. 
1H-15N HMQC spectra were acquired 
as described above. Cell lysate samples for NMR experiments comprised 90:10 (v:v) 
mixture of cell lysate: D2O in a standard 5 mm NMR tube. 
1H-15N HMQC spectra were 
acquired as described above. 
 
2.3 Results and Discussion 
1H-15N SOFAST HMQC spectra of E. coli expressing the periplasmic protein 
HdeA were obtained 3 h after inducing with IPTG (Fig 2.5.1). Protein resonances were 
visible in the cell slurry (Fig 2.5.1A). To check for leakage, the slurry was centrifuged 
and a spectrum of the supernatant acquired. The spectrum of the slurry showed a 
strong protein signal (Fig 1B), similar to that observed in the lysate (Fig 1C). The 
observation of HdeA crosspeaks in the supernatant indicates leakage. The approximate 
periplasmic protein concentration after 3 h of expression is shown in Table 2.6.1.  
To assess if expression levels contribute to leakage, the spectrum of the cell 
slurry that had been allowed to express HdeA for only 1.5 h was acquired (Fig 2.5.2).  
Crosspeaks characteristic of HdeA are not observed (Fig 2.5.2A,B) but metabolite 
signals are observed [36]. In comparison, the lysate contains resonances typical of 
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HdeA (Fig 2.5.2C). We then determined the amount of HdeA/cell after 1.5 h of 
expression (Table 2.6.1).  
We also examined the protein CI2 (Fig. 2.5.3). After 1.5 h of expression, 
crosspeaks from CI2 are not visible in the cell slurry or cell supernatant (Fig 2.5.3A,C), 
but are visible in the lysate (Fig 2.5.3E). Spectra collected after 3 h of expression show  
leakage (Fig 2.5.3 B,D,F), in agreement with other results [27]. The amount of CI2/cell 
after 1.5 and 3 h of expression are given in Table 2.6.1.  
We also examined the proteins α-synuclein and ubiquitin. Spectra like those 
collected in Figures 1 and 2 for these proteins show that they do not leak, in agreement 
with a previous study [27]. The amounts for these proteins per cell after 1.5 and 3 h of 
expression are given in Table 2.6.1.  
We compared location and concentrations for four proteins in E. coli cells to the 
observation of leakage. Ubiquitin and HdeA are exclusively localized in the cytoplasm 
and periplasm respectively [30, 32]. CI2 and α-synuclein, however, have been shown to 
localize in both the periplasmic and cytoplasmic regions of the cell [11, 27]. For this 
reason, the amount of protein expressed per cell was determined and then used to 
calculate the intracellular concentrations. The results in Table 2.6.1 suggest that 
leakage is associated with high intracellular concentrations.  
We showed that leaking begins if intracellular concentrations of approximately 
7.5 ±0.7 mM are exceeded for proteins that are exclusively expressed in the periplasm. 
For a protein found throughout the cell like CI2, intracellular concentrations exceeding 
20.2 ±0.9 mM results in leakage. In comparison, α-synuclein is found throughout the cell 
but has an intracellular concentration of only 4.0 ±1.1 mM after 3 h of expression. Thus, 
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leakage does not occur for proteins expressed at lower levels. Our conclusion is 
supported by previous results on CI2, which showed this protein does not leak when 
expressed using the less efficient trifluoromethyl-L-phenylalanine expression system 
[27].  
Assuming that expression of other proteins is decreased to maintain the 400 g/L 
cellular concentration while our protein is overexpressed, we were able to determine the 
percentage of our protein’s mass to the mass of total cellular protein. We calculated that 
20-25% of the macromolecular mass in the cell is our protein before leaking begins. For 
the protein CI2, leaking is observed at the intracellular concentrations of 20.2 ±1.0 mM, 
which equates to approximately 37%.  
Although highly expressed proteins leak, the mechanism is unknown. Li et al 
estimated that the total amount of CI2 found in the supernatant of the cell slurry is 
approximately 5-10% [27]. Previous in-cell NMR experiments performed in E. coli show 
that approximately 90-95% of the cells remain viable [37]. These data suggest that the 
CI2 found in the supernatant is the product of cell lysis. CI2, normally a cytoplasmic 
protein, is also found within the periplasmic space after overexpression [27]. This 
observation suggests that passive exocytosis may also contribute to protein leakage.  
 
2.4 Conclusion 
In summary, we have shown that overexpression can lead to leakage if the 
intracellular concentration of the protein exceeds ~10 mM. In-cell NMR experiments in 
E. coli should consider this expression limit so that valid data are obtained within the 
cell. For globular proteins, the leaked protein contributes to 100% of the 1H -15N NMR 
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spectrum because the intracellular environment broadens 1H -15N crosspeaks beyond 
detection [27]. Future in-cell NMR experiments in E.coli cells should consider 
intracellular concentrations low enough to obtain valid in-cell data. 
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2.5 Figures 
 
Figure 2.3.1.  In-cell SOFAST 15N – 1H HMQC spectra (37°C) of E. coli expressing 
HdeA after 1.5 h.  
Panel A: In-cell spectrum. Panel B: Spectrum of supernatant acquired immediately after 
acquisition of in-cell spectrum. Panel C:  Spectrum of cell lysate.  
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Figure 2.2.3.  In-cell SOFAST 15N – 1H HMQC spectra (37°C) of E. coli expressing 
HdeA after 1.5 h.  
The panels are described as in the legend to Figure 2.1. 
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Figure 2.5.3. In-cell SOFAST 15N – 1H HMQC spectra (37°C) of E. coli expressing 
CI2 after 1.5 h (left panels) and 3 h (right panels).  
Panels A-B: In-cell spectra. Panels C-D: Spectra of supernatant immediately after 
acquisition of in-cell spectra. Panels E-F: Spectra of cell lysate. 
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Table 2.6.1. Protein Intracellular Concentrations 
 
Table I. Intracellular Concentrationsa  
 
Protein 
 
 
 
      Expression Level (fg/cell) 
    
  
After 1.5 h 
 
After 3 h 
 
Location  
 
HdeA 
 
90 ± 10b 
 
140 ±10 
 
Periplasim 
α-Synuclein 30 ± 10 60 ± 20c Periplasm/Cytoplasm 
Chymotrpysin 
Inhibitor 2 
80 ±10 150 ±10 Cytoplasm/Periplasm 
Ubiquitin 10 ± 5 40  ±10 Cytoplasm 
aQuantified by integrating pixel intensities of bands from Coomassie-stained 
SDS PAGE and comparing them against standards of the pure proteins. 
bStandard error, n=4. cDoes Not Leak 
 
 
 3 A Bioreactor for in-cell protein NMR 
3.1 Introduction  
Most biophysical experiments on investigate proteins are conducted in dilute 
solution.  Most proteins, however, serve their physiologically relevant function in cells, 
which have a complex crowded environment that affect several protein properties 
compared to dilute solution [38-41]. For this reason, there is an increasing interest in 
studying proteins inside living cells. Nuclear magnetic resonance spectroscopy (NMR) 
has become a popular tool for experiments on living cells because it provides atomic-
level information about cellular components and is nondestructive [42].  
A disadvantage of NMR spectroscopy is its low sensitivity. Selective isotopic 
enrichment or labeling of the targeted species with an NMR active nucleus (e.g., 15N, 
13C or 19F)  is one way around this problem. Serber et al. suggest that the minimum 
concentration of the protein under study should be at least ~150 µM for 15N enrichment 
or ~50 µM for 13C enrichment [21]. Therefore, the target protein must be overexpressed 
or introduced into the cell by other means (e.g., micro injection, cell penetrating peptides 
[42]). To increase sensitivity further, high cell densities (109-1011 cells/mL) are used, and 
the data are time averaged.   
Current experimental setups for protein in cell NMR have several drawbacks. 
First, the lack of aeration and the high cell density create an anaerobic environment. 
Second, metabolites and waste products accumulate. These characteristics can 
decrease cell viability, limiting the cell types that can be used, and make it difficult to 
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monitor temporal changes. Overcoming these challenges requires an NMR compatible 
device that maintains cell viability.   
 Devices with these characteristics have been developed. One type is an in-
magnet bioreactor that enables growth of microorganisms to a high density [43, 44].  
Another type is a perfusion system that flows media down through immobilized cells 
[45, 46].  These devices tend to be complex and difficult to fabricate. Furthermore, they 
are designed for studying metabolism.  
Here, we describe a circulating encapsulated cells (CEC) bioreactor and 
accessories for in-cell protein NMR. The instrument comprises parts that are 
commercially available or easily fabricated. The expression of the natively disordered 
human protein α-synuclein in Escherichia coli is used to demonstrate its capabilities. α-
Synuclein is a 14.5 kDa protein implicated in the pathogenesis of Parkinson’s disease 
[47]. The expression of the plasmid borne α-synuclein gene is controlled by a lactose 
inducible, phage T7 promoter. We investigate the bioreactor’s ability to maintain cell 
viability and measure the accumulation of α-synuclein with time. 
 
3.2 Materials and Methods 
3.2.1  Purification of wild type α-synuclein for in vitro experiments 
 The pT7-7 plasmid containing the α-synuclein gene was transformed into E. coli 
Bl-21 (DE3) Gold cells (Strategene). Plasmid containing cells were selected with 0.1 
mg/mL ampicillin. A 5 mL overnight culture was grown from a single colony and used to 
inoculate a 50 mL culture of Spectra 9 15N-enriched media (Cambridge Isotope 
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Laboratories) at 37°C in a rotary shaker (225 rpm, New Burnswick Scientific, Model I-
26). The saturated overnight culture was used to inoculate 1 L of M9 minimal media [48] 
containing 1 g/L 15NH4Cl. After reaching an absorbance at 600 nm (A600) of 0.8-1.0, the 
culture was induced with isopropyl β-D-thiogalactopyranoside (IPTG) to a final 
concentration of 1 mM. The culture was placed in the rotary shaker (225 rpm) at 37°C. 
After 5 h the cultures were pelleted using a swinging bucket centrifuge (Sorvall 
RC-3B, H6000A rotor) at 1600g for 30 min at 4°C and the pellet was stored at -20°C. 
The pellet was resuspended in 30 mL of lysis buffer (50 mM Tris, 150 mM NaCl, 1 mM 
phenylmethanesulfonyl fluoride, 0.4 g/L lysozyme, pH 8.0).  RNase and DNase were 
added to a final concentration of 0.02 g/L each. The samples were stirred (250 rpm) at 
4°C for 20 min. The lysate was sonicated (Branson Ultrasonics, Fischer Scientific) 
continuously for 5 min, boiled in a water bath for 20 min, and then centrifuged at 
13,000g for 30 min at 4°C (SS-34 rotor). The supernatant was subjected to streptomycin 
sulfate precipitation (10 g/L) and centrifuged for 30 min at 4°C. The supernatant was 
subjected to (NH4)2SO4 precipitation (361 g/L) and centrifuged again for 30 min at 4°C. 
The pellet was resuspended in 20 mM sodium phosphate buffer (pH 7.4) and dialyzed 
(Thermo Scientific, 3500 MWCO) overnight, with stirring at 4°C, against the same 
buffer.  
The protein was further purified by anion exchange chromatography 
(GEHealtcare, Q Sepharose HiPrep 16/10 column) with a 0-1 M linear gradient of NaCl 
in 20 mM phosphate buffer (pH 7.4). Fractions were subjected to SDS-PAGE on an 
18% gel with Commassie blilliant blue staining. Fractions containing α-synuclein were 
pooled and dialyzed against water overnight, with stirring, at 4°C. The protein was 
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concentrated in a YM-3 Centricon filter (Millipore, MWCO 3500) using centrifugation at 
1000g (SS-34 rotor) for 1 h at 4°C. The purity of the protein was determined by SDS-
PAGE with Coomassie staining. The pure α-synuclein was lyophilized (Labconco) and 
stored at -20°C. The yield was 35-60 mg of pure α-synuclein per liter of saturated cell 
culture.  
 
3.2.2  Cultivation of E. coli for in-cell NMR experiments 
 A 5 mL overnight culture was grown from a single colony and used to inoculate a 
500-mL Erlenmeyer flask containing 50 mL of isotopically enriched media, as described 
above. After the culture reached an A600 of 0.8-1.0, the cells were induced with IPTG to 
a final concentration of 1 mM. Expression was allowed to proceed for 4 h. The cells 
were gently harvested by using the swinging bucket centrifuge for 30 min at 4°C. The 
pellet was resuspended in 1 mL of spent media. 
 
3.2.3  Cultivation and encapsulation of E. coli for NMR bioreactor 
experiments 
 A 5 mL overnight culture was grown from a single colony as described above and 
used to inoculate 150 mL of Luria Broth (10 mg/mL Tryptone, 5 mg/mL yeast extract, 10 
mg/mL NaCl) at 37°C. The culture was grown in the rotary shaker (225 rpm) to an A600 
of 0.8-1.0. The cells were gently harvested in the swinging bucket centrifuge for 20 min 
at 4°C and resuspended in 1 mL of spent media. The resuspended cells were mixed 
with a 2% w/v alginate (Sigma) solution in 20 mM phosphate, 150 mM NaCl (pH 7.4) to 
give a final concentration of 1% alginate (50:50 mixture alginate:cell slurry).  
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The electrostatic encapsulation device (Fig. 3.5.7) comprised a 1 mL insulin 
syringe (BD), a 24 gauge winged anigocatheter (0.7 x 19 mm tip, Braun), a 23 gauge 
needle (BD), a syringe pump (Braintree Scientific 8000), and an adjustable high voltage 
power supply (Spellman SL10). The insulin syringe, equipped with the needle, was 
loaded with the cell/alginate mixture.  The other needle, which was inserted horizontally 
through the center of the angiocatheter, was connected to the positive pole of the power 
supply. The negative pole of the power supply was placed into the 150 mM CaCl2 
solution. The syringe containing the mixture was inserted into the top of the 
angiocatheter and placed onto the pump. The syringe pump was set to a rate of 0.714 
mL/min, the power supply voltage to 3.35 kV, and the stir-plate to approximately 300 
rpm. The tip of the angiocatheter was centered 1.2 cm above a 250 mL beaker 
containing 150 mL of 150 mM CaCl2. The mixture was forced through the tip of the 
angiocatheter and streamed into the CaCl2 solution.  The Ca
2+ polymerizes the alginate 
which, in turn, forms encapsulated beads containing the cells. The encapsulated cells 
were retrieved with suction and placed in a 15 mL Falcon tube containing 150 mM 
CaCl2 solution for transport to the NMR spectrometer.  
The CaCl2 solution was removed and the encapsulated cells were washed with 
the phosphate-free minimal medium. The phosphate-free minimal medium consisted of 
100 mM HEPES (pH 7.4), 150 mM CaCl2, phosphate-free M9 salts  [1mg/mL 
15NH4Cl, 2 
mM MgCl2, 1 µg/mL thiamine, 2 % v:v 10x 
15N-enriched Bioexpress  1000 media 
(Cambridge Isotope Laboratories)] and 0.1 mg/mL ampicillin. After washing, the 
encapsulated cells were placed inside the bioreactor, which was then placed into the 
spectrometer. After acquiring the initial spectrum, lactose was added to a final 
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concentration of 1% w/v. The lactose acts as an inducer and the sole carbon source. 
For each spectrum, the pump circulated medium through the system at a rate of 45 
mL/min for 30 min. Five min were allotted for the encapsulated cells to settle into the 
detection region of the bioreactor. As a control the procedure was repeated for E. coli  
containing the pUC18 plasmid.  
 
3.2.4  NMR 
 Data were acquired at the UNC Biomeolcular NMR facility on a Varian Inova 600 
MHz NMR spectrometer. Data were processed and visualized with NMRpipe and 
NMRviewJ, respectively [34, 35].  
Samples for dilute solution spectra comprised a 90:10 (v:v, pH 7.4) mixture of 
purified 200 µM α-synuclein solution: D2O in a standard 5 mm NMR tube. 
1H-15N HSQC 
spectra were acquired at 10oC [1] with a 5 mm Varian Triax triple resonance probe (1H 
sweep width: 11990.40 Hz; 15N sweep width: 2100 Hz, 8 transients, 128 increments).  
Each spectrum required 35 min.  
Samples for simple in-cell NMR experiments comprised 90:10 (v:v) mixture of 
resuspended cells: D2O in a standard 5 mm NMR tube. 
1H-15N HSQC [49, 50] spectra 
were acquired as described above, except with 12 transients and 128 increments.  Each 
spectrum required 1 h. 
Samples for encapsulated in-cell NMR experiments comprised encapsulates in a 
90:10 (v:v) mixture of 150 mM CaCl2: D2O in a standard 5 mm NMR tube. For 
encapsulates in standard 5 mm NMR tubes, 1H-15N HSQC spectra were acquired as 
described above. In the bioreactor, 1H-15N HSQC spectra were acquired unlocked at 
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37oC with an 8 mm modified Varian Triax triple resonance z gradient probe as 
described above. Samples for NMR bioreactor experiments comprised encapsulated 
cells in phosphate-free media supplemented with Bioexpress 1000. 1H-15N SOFAST 
HMQC spectra were acquired unlocked at 37oC as described above, except with 48 
transients and 96 increments. Each spectrum required 35 min.  
 
3.3 Results  
3.3.1 The CEC bioreactor 
The bioreactor is made from Teflon to facilitate NMR experiments involving 1H 
detection (We have made a similar version from Plexiglass for 19F detection). It consists 
of three main parts; an 8 mm diameter tube, a circulation chamber, and an adjustable 
threaded cap (Fig. 3.5.1).  An inlet for an Upchurch Scientific Super Flangeless Fitting is 
located on the upper part of the cap (Fig. 3.5.1E). A 1/16” OD inlet for Upchurch 
Scientific perfluoro alkoxy alkane tubing is located at the bottom (Fig. 3.5.1A).   
Most of the components (Fig. 3.5.2) are commercially available. The liquid media 
is contained in a 1 L Corning  three neck spinner flask with a tubing adaptor on one side 
arm (Fig. 3.5.2A). A peristaltic MasterFlex pump (Fig. 3.5.2B), moves the media at a 
rate of 45 ml/min from the flask, through the tubing adaptor, into the PFA tubing (Fig. 
3.5.2, yellow lines).  The tubing runs from the pump, into the bottom of an 8 mm Varian 
triple resonance z gradient probe through an opening created by removing the heater 
(Fig. 3.5.2D). The temperature is controlled with the spectrometer’s FTS 
Systems heating apparatus (Model TC-84).  PFA tubing between the pump and the 
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bioreactor is placed in a Fisher Scientific Isotemp water bath to warm the media (Fig. 
3.5.2C), which flows from the bottom of the bioreactor to the top (Fig. 3.5.1, arrows on 
right side). The PFA tubing at the top of the bioreactor returns the media, via a pH 
probe, to the 1 L the Corning three neck spinner flask.  The pH probe, pump and NMR 
spectrometer are connected to a laptop computer (Fig. 3.5.2, green lines).   
The 1H-15N band-selective optimized flip-angle short transient (SOFAST) 
heteronuclear multiple quantum coherence (HMQC) [51] pulse program provided in the 
Varian Biopak suite of pulse sequences  was modified to send voltage outputs to the 
computer. The signals are interpreted by LabView (National Instruments) software, 
which controls the pump.  The software also records the pH value at 1 min intervals. 
Cells are electrostatically encapsulated into 1 mm diameter Ca2+ alginate 
spheres to keep them in the bioreactor [52]. The circulation of the encapsulated cells 
facilitates the delivery of nutrients and waste removal.  The bioreactor (Fig. 3.5.1) has 
two states: pump off, and pump on.  When the pump is off, encapsulated cells settle into 
the 8 mm diameter tube for data acquisition (Fig. 3.5.1, left panel). When the pump is 
on, the encapsulates travel from the 8 mm diameter tube into the wider circulation 
chamber. The movement of the encapsulates from a narrow to wider tube results in a 
reduction in pressure causing the encapsulates to circulate in the chamber (Fig. 3.5.1, 
right panel). The pulsed, upward motion also prevents the encapsulates from clogging 
the outlet of the cell chamber. 
 
3.3.2 CEC bioreactor without flowing media 
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To assess the bioreactor’s suitability for in cell NMR experiments, the 1H-15N 
HSQC spectrum of encapsulated E. coli in the bioreactor is compared to the HSQC 
spectrucm of 15N enriched α-synuclein obtained in a conventional 5 mm NMR probe 
(Fig. 3.5.3A,B). The in vitro spectrum of purified α-synuclein (Fig. 3.5.3C) is shown as a 
reference. The similarity of the spectra indicates that α-synuclein can be detected in the 
bioreactor.  
To assess the bioreactor’s effect on spectral quality, the in cell HSQC spectrum 
of encapsulated E. coli expressing 15N enriched α-synuclein in the bioreactor is 
compared to the HSQC spectrum of the same encapsulates in a 5 mm tube (Fig. 
3.5.3A,D). The spectrum of the encapsulated cells in the 5 mm tube is consistent with 
the published spectrum [53]. The crosspeaks broaden when encapsulates are placed in 
the bioreactor, but the quality of spectra is only slightly degraded.  
 
3.3.3 CEC bioreactor with flowing media 
The expression of α-synuclein was monitored with the 1H-15N SOFAST HMQC 
pulse sequence, rather than the HSQC sequence, to obtain higher sensitivity and 
decrease acquisitions times. Spectra as a function of time are shown in Fig. 3.5.4A-C. 
The spectrum of the encapsulates before induction (Fig. 4A) has few crosspeaks and no 
unambiguous α-synuclein crosspeaks. After induction new crosspeaks begin to appear. 
With each successive spectrum, the crosspeaks increase in volume as seen at 4 h and 
18 h (Figs. 3.5.4B,C). Using methods described by Slade et al. [54] we determined the 
intracellular concentration of α-synuclein to be 0.8 mM at 18 h.  
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As a control, the encapsulates were removed after the experiment and a 
spectrum was acquired of the surrounding media (Fig. 3.5.4D). The spectrum shows 
only a weak crosspeak, indicating that the bulk of the signal comes from the 
encapsulated cells.  The viability of the E. coli in the bioreactor experiments was 
determined by plating serial dilutions of dissolved encapsulates before and after each 
experiment.  The viability was 95%. The pH of the medium perfused around the 
encapsulated cells remained at 7.00 for the duration of the experiment. 
Although the CEC bioreactor provides an environment where encapsulated E. 
coli cells express α-synuclein, the lower resolution of SOFAST HMQC spectra can 
make it difficult to distinguish between metabolites and protein crosspeaks. To 
determine which crosspeaks corresponded to α-synuclein, we collected spectra of fresh 
media (Fig 3.5.5A) and of E. coli containing a pUC18 plasmid [55] without the α-
synuclein gene (Fig 3.5.5B). Overlaying these spectra with the spectrum of α-synuclein 
expressed in the bioreactor (Fig 3.5.5C), shows that most of the crosspeaks are from α-
synuclein (Fig 3.5.5D).  
The overlay allowed us to quantify temporal changes in crosspeak volumes (Fig 
3.5.6). The crosspeak from the defined minimal media is the only crosspeak detectable 
at 30 min (Fig 3.5.6H). Although induction occurred at 30 min, there was a lag phase of 
approximately 4 h before crosspeaks could be detected (Fig 3.5.6A-B, E-G). Some 
crosspeaks are not detectable until approximately 7 h (Fig 3.5.6C,D),  
The volumes of α-synuclein crosspeaks increased with time, beginning with a lag 
phase before growing exponentially to a plateau (Fig 3.5.6A-E). One crosspeak 
deviated from this trend (Fig 3.5.6D), most likely because the poor resolution in this 
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area of the spectrum (Fig 3.5.5D). Temporal changes in crosspeak volumes for two 
metabolites showed different trends. One metabolite remained constant (Fig 3.5.6F), 
while the other metabolite showed a time dependence that resembled the α-synuclein 
crosspeaks (Fig 3.5.6G). The crosspeak from the defined minimal media, is the only 
crosspeak that showed a slight decrease in intensity with time (Fig 3.5.6H). 
 3.4 Discussion 
The CEC bioreactor (Fig. 3.5.1) is designed to provide a controlled environment 
for NMR experiments involving living cells.  It allows media to deliver nutrients and 
remove waste from encapsulated cells contained in a circulation chamber (Fig. 3.5.1, 
right panel). When the flow of media is stopped, the encapsulated cells settle allowing 
data acquisition (Fig. 3.5.1, left panel).  
In the experimental setup, the CEC bioreactor is the only component located 
inside the spectrometer (Fig. 3.5.2). This configuration allows the external components 
to be altered without removing the bioreactor before or during the experiment, 
facilitating studies requiring different conditions in one experiment. The setup is also 
versatile. Different solution probes and sensors can be inserted between the external 
components.  The tubing can be rerouted, for example, to send the media to a waste 
container. In addition, the material used to make the bioreactor can be changed for 
experiments requiring different isotopic nuclei detection. Here we use Teflon for 15N 
detection, but a Plexiglass bioreactor can be used for 19F NMR.  
To our knowledge, the CEC bioreactor is the first bioreactor suitable for protein in 
cell NMR experiments (Fig. 3.5.3A,B). The design provides an environment where 
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encapsulated cells can express protein while maintaining reasonably high quality in cell 
NMR spectra (Fig 3.5.3C-D). Furthermore, the bioreactor can be used to quantify 
temporal changes in crosspeak volumes during the experiment (Fig. 3.5.4 and 5).   
Our data allow us to draw several conclusions. We showed that α-synuclein was 
present at an intracellular concentration of 0.8 mM at 18 h. Using information from 
Figure 6, we conclude that the detection limit for in-cell NMR is approximately 0.14 mM.  
This finding is consistent with other work on the minimal intracellular protein 
concentration needed for in-cell NMR [6]. For most residues, the detection limit is 
achieved after 3 h. Two protein crosspeaks do not follow this trend in that they are not 
detectable until approximately 7 h (Fig. 3.5.6 C,D). The crosspeaks from glycine 
residues that comprise the ear shaped pattern in the upper left region of α-synuclein 
Figure 3.5.4 (15N ppm 108-113, 1H ppm 8.3-8.7), follow a similar trend. The delay in 
detectability may be due to differential binding of α-synuclein to other intracellular 
components, which broadens their crosspeaks. Another possibility for the delay is 
differential relaxation, because in vitro models for α-synuclein dynamics show that 
certain residues experience less mobility [17]. Decreased mobility produces broader, 
weaker signals, which would explain the longer time required to detect them.  
 
3.5 Conclusion 
In summary, the CEC bioreactor provides a controlled environment where protein 
NMR spectra data can be acquired in living E. coli cells. Our next goal is to show that 
the CEC bioreactor is compatible with other cell types, and is versatile enough for 
metabolomic, as well as protein NMR experiments. We specifically want to focus on 
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eukaryotic cells whose viability is adversly affected by current methods. Progress has 
been made in maintaining the viability of CHO cells using our device for 48 h, but other 
cell lines have yet to be tested. Our long-term goal is to monitor temporal changes in 
protein structure and metabolism due to perturbations, such as drug interactions, in 
human cells, and so increase the understanding of intracellular components under 
physiological conditions. 
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3.6 Figures  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6.1. The CEC bioreactor. 
 On the left, the pump is off and the encapsulates are settled. On the right, the pump is 
on and the encapsulates circulate at a steady state in the upper chamber. A: tubing 
inlet, B: NMR detection region, C: circulation chamber, D:  adjustable threaded cap, E: 
fitting inlet.  Orange circles represent encapsulates containing E. coli cells. 
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Figure 3.6.2.  The experimental set-up. 
 A: Corning spinner flask fitted with a vented cap on one side arm and tubing adaptors 
on the other, B: peristaltic pump, C: water bath, D: 8 mm probe with heater removed, E: 
bioreactor, F: magnet, G: pH probe, H: computer, I: stir plate. 
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Figure 3.6.3.  Comparing α-synuclein spectra.  
Panel A: In cell HSQC spectrum of alginate encapsulated E. coli expressing α-synuclein 
in the bioreactor. Panel B: In cell HSQC spectrum of E. coli expressing α-synuclein. 
Panel C:  In vitro HSQC spectrum of 200 µM purified wild type α-synuclein in HEPES 
buffer, pH 7.2 at 10°C. Panel D: In cell HSQC spectrum of alginate encapsulated E. coli 
expressing α-synuclein. The spectra shown in panels A, B & D were acquired at 37°C. 
The spectra in panels B-D were acquired in a 5 mm NMR tube using a 5 mm probe. The 
spectrum in panel A was acquired in the 8 mm bioreactor using an 8 mm probe.  
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Figure 3.6.4. In-cell SOFAST 15N-1H HMQC [12] spectra  (37°C) of E. coli 
expressing α-synuclein in the bioreactor. 
Panel A: Spectrum collected before induction. Panel B: 4 h post induction. Panel C: 18 
h post induction. Panel D: Spectrum of the spent medium. 
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Figure 3.6.5. Determining which crosspeaks correspond to α-synuclein.  
Panel A: In-cell SOFAST 15N-1H HMQC spectrum of the defined phosphate-free minimal 
media. Panel B: Spectrum of 15N encriched encapsulated E. coli cells containing the 
control pUC18 plasmid. Panel C: Spectrum of encapsulated E. coli expressing α-
synuclein. Panel D: Overlay of the spectra [medium (red), puc18 control cells (cyan), 
and α-synuclein (black)]. Crosspeaks used in subsequent analysis are labeled a-h. 
Spectra were acquired in the 8 mm bioreactor using an 8 mm probe at 37°C.  
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Figure 3.6.6. Temporal changes in crosspeak volume after inducing α-synuclein 
expression in the bioreactor.  
Panels A-E: α-Synuclein crosspeaks. Panel F-G: Metabolite crosspeaks. Panel H: 
Crosspeaks from the defined phosphate free minimal media. Crosspeak volumes are 
normalized to the largest volume and are labeled in Figure 5D. Error bars represent the 
standard error from three independent experiments. 
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Figure 3.6.7.  Schematic of the electrostatic encapsulation device.  
A: stir plate, B: beaker containing 150 mM CaCl2, C: anigocatheter, D: needle, E: insulin 
syringe, F: alligator clip (connects the positive power supply terminal to the needle) G: 
high voltage power supply, H: ground, I: negative end. 
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